Explore the latest AI-assisted rehabilitation techniques for musculoskeletal disorders, highlighting top technologies for pain relief, functional recovery, and range of motion improvement.
Merck has entered an expanded $349 million collaboration with Variational AI to leverage generative AI technology for designing small molecule drug candidates targeting challenging biological pathways.
Merck Expands AI Drug Discovery Partnership with Variational AI in $349M Deal Read More »
Synthesize Bio, founded by Fred Hutch researchers, secures $10M seed funding to advance AI generative genomics models aimed at transforming biotech research and drug discovery.
Synthesize Bio Launches AI-Driven Generative Genomics Startup with $10M Seed Funding Read More »
Discover how AI-driven machine learning is transforming drug discovery in biotechnology, enabling faster results, improved accuracy, and shaping the future of personalized medicine.
AI’s Next Frontier in Biotech: Accelerating Drug Discovery with Machine Learning Read More »
Explore China’s strategic overhaul of higher education focusing on AI and biotechnology to align talent development with national innovation goals and shape the future of global tech leadership.
China’s Higher Education Reform: Advancing AI and Biotechnology Talent Read More »
Discover how Rakovina Therapeutics uses AI-driven platforms to accelerate DNA Damage Response cancer therapies, focusing on central nervous system tumors and promising new drug candidates.
Discover SK Group and AWS’s $61 billion investment in South Korea’s Ulsan AI data center, spearheading AI-driven biotechnology and creating 78,000 jobs by 2030.
SK Group and AWS Launch AI Data Center in Ulsan, Driving AI-Powered Biotech Innovation Read More »
